"The ETHIC Act would limit the ability of patent owners to assert more than one patent from the same 'Patent Group' in a patent infringement action, with the goal of addressing so-called patent thickets."
"Pro-patent groups like the Council for Innovation Promotion (C4IP) have called this narrative 'misleading,' stating that many patents can be necessary to capture the full scope of all the inventions in sophisticated and complicated products."
A coalition representing consumers, patients, and healthcare providers has urged the U.S. House Judiciary Committee to advance the ETHIC Act. This legislation seeks to limit patent owners from asserting multiple patents from the same Patent Group in infringement actions. The goal is to reduce patent thickets, which are criticized for hindering generic drug entry. Pro-patent advocates argue that the narrative surrounding patent thickets is misleading, emphasizing that multiple patents can be essential for complex products and that patent numbers do not correlate with generic entry timing.
Read at IPWatchdog.com | Patents & Intellectual Property Law
Unable to calculate read time
Collection
[
|
...
]